Infecting kidney organoids with a cDNA reporter clone of SARS-CoV-2

STAR Protoc. 2022 Jul 21;3(3):101617. doi: 10.1016/j.xpro.2022.101617. eCollection 2022 Sep 16.

Abstract

Induced pluripotent stem cell (iPSC)-derived kidney organoids can be used for disease modeling and drug testing. Here, we describe a protocol to prepare stocks of an infectious clone of SARS-CoV-2 expressing a stable mNeonGreen reporter (icSARS-CoV-2-mNG). We demonstrate the infection of kidney organoids, primarily at the proximal tubular cells, with icSARS-CoV-2-mNG. Using a TCID50 (tissue culture infectious dose 50) assay and confocal microscopy, we show the quantification of SARS-CoV-2-mNG signal in proximal tubular cells of the kidney organoids. For complete details on the use and execution of this protocol, please refer to Rahmani et al. (2022).

Keywords: Cell-based assays; Organoids; Stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Clone Cells
  • DNA, Complementary / genetics
  • Humans
  • Kidney
  • Organoids
  • SARS-CoV-2* / genetics

Substances

  • DNA, Complementary

Grants and funding